Brachytherapy: A critical component of primary radiation therapy for cervical cancer: From the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS).
Brachytherapy
Cervical cancer
IMRT
Primary chemoradiation
SBRT
Journal
Gynecologic oncology
ISSN: 1095-6859
Titre abrégé: Gynecol Oncol
Pays: United States
ID NLM: 0365304
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
28
08
2018
revised:
11
10
2018
accepted:
15
10
2018
pubmed:
23
1
2019
medline:
18
4
2019
entrez:
23
1
2019
Statut:
ppublish
Résumé
Brachytherapy is well-established as an integral component in the standard of care for treatment of patients receiving primary radiotherapy for cervical cancer. A decline in brachytherapy has been associated with negative impacts on survival in the era of modern EBRT techniques. Conformal external beam therapies such intensity modulated radiation therapy (IMRT) or stereotactic body radiation therapy (SBRT) should not be used as alternatives to brachytherapy in patients undergoing primary curative-intent radiation therapy for cervical cancer. Computed tomography or magnetic resonance image-guided adaptive brachytherapy is evolving as the preferred brachytherapy method. With careful care coordination EBRT and brachytherapy can be successfully delivered at different treatment centers without compromising treatment time and outcome in areas where access to brachytherapy maybe limited.
Identifiants
pubmed: 30665615
pii: S0090-8258(18)31297-6
doi: 10.1016/j.ygyno.2018.10.016
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
540-547Informations de copyright
Copyright © 2018 Elsevier Inc., American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.